Company / Working Capital per Share
AXIM BIOTECHNOLOGIES, INC. Working Capital per Share History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$0.03
FY2023
5-year range
-$0.11 / -$0.02
FY2019-FY2023
Trend
-27.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.02 to $-0.03 over the past 5 years.
Based on SEC 10-K filings.
-0.03 in FY2023.
Declined from $-0.02 to $-0.03 over the past 5 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, working capital per share decreased 27.0% year-over-year.
- Peak working capital per share was recorded in FY2011.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$0.03 | -27.0% |
| FY2022 | -$0.02 | +0.2% |
| FY2018 | -$0.02 | +77.6% |
| FY2017 | -$0.11 | -156.9% |
| FY2016 | -$0.04 | -0.4% |
| FY2015 | -$0.04 | -823.2% |
| FY2013 | -$0.00 | -50.0% |
| FY2012 | -$0.00 | -53.1% |
| FY2011 | -$0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026